You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Proton beam therapy for a patient with prostatic rhabdomyosarcoma: a case report and review of the literature
- 2. Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
- 3. AI Can Boost Radiologists' Efficiency Without Sacrificing Accuracy
- 4. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in lung carcinoid patients after receiving curative surgery. A multicentre study
- 5. LUNG CANCER RESEARCH FOUNDATION EXPANDS RESEARCH ADVOCATES
- 6. Results from Phase 1/2 Study of Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology
- 7. Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer
- 8. IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes
- 9. Celebrity Diagnoses Underscore Rising Breast Cancer Rates in Young Women
- 10. Dual regulation of the cGAS-STING pathway: new targets and challenges for subtype-specific immunotherapy in breast cancer
Last updated at 20:57 GMT
Hot News Makers
Health/Pharma Companies
-
144065.98
-
19626.11
-
18975.76
-
18240.73
-
18030.98
-
15342.15
-
13992.04
-
13052.28
-
12491.86
-
9482.87
Drugs, Treatments, Trials
-
35007.09
-
7601.50
-
7271.00
-
6867.64
-
5720.10
-
4860.41
-
4030.79
-
2463.26
-
2054.53
-
2010.21
Last updated at 20:10 GMT
